Authors:
Ouyang, XM
Gulliford, T
Zhang, HY
Smith, G
Huang, GC
Epstein, RJ
Citation: Xm. Ouyang et al., Association of ErbB2 Ser(1113) phosphorylation with epidermal growth factor receptor co-expression and poor prognosis in human breast cancer, MOL C BIOCH, 218(1-2), 2001, pp. 47-54
Citation: Gl. Smith et al., Dual X-ray absorptiometry detects disease- and treatment-related alterations of bone density in prostate cancer patients, CLIN EXP M, 18(5), 2001, pp. 385-390
Citation: T. Gulliford et al., Intensification of growth factor receptor signalling by phorbol treatment of ligand primed cells implies a dimer-stabilizing effect of protein kinaseC-dependent juxtamembrane domain phosphorylation, CELL SIGNAL, 11(4), 1999, pp. 245-252
Citation: Gc. Huang et al., Overexpression of ErbB2 impairs ligand-dependent downregulation of epidermal growth factor receptors via a post-transcriptional mechanism, J CELL BIOC, 74(1), 1999, pp. 23-30
Authors:
Smith, GL
Doherty, AP
Mitchell, H
Hanham, IW
Christmas, TJ
Epstein, RJ
Citation: Gl. Smith et al., Inverse relation between prostate-specific antigen and insulin-like growthfactor-binding protein 3 in bone metastases and serum of patients with prostate cancer, LANCET, 354(9195), 1999, pp. 2053-2054
Authors:
Ouyang, XM
Gulliford, T
Doherty, A
Huang, GC
Epstein, RJ
Citation: Xm. Ouyang et al., Detection of ErbB2 oversignalling in a majority of breast cancers with phosphorylation-state-specific antibodies, LANCET, 353(9164), 1999, pp. 1591-1592
Authors:
Doherty, A
Smith, G
Banks, L
Christmas, T
Epstein, RJ
Citation: A. Doherty et al., Correlation of the osteoblastic phenotype with prostate-specific antigen expression in metastatic prostate cancer: Implications for paracrine growth, J PATHOLOGY, 188(3), 1999, pp. 278-281